Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)

Ramón Cacabelos
Institute of Medical Science and Genomic Medicine
Corunna
Spain

Back

Become EABM
Become Reviewer

Open Access Articles

HLA-B27 is a Risk Factor for Rheumatoid Arthritis: Suggestion for an Evidence-based Update open Access plus

Volume: 17  
Pp: 1-4
Seyyed Amir Yasin Ahmadi, Reza Mohammadrezaei-Khorramabadi, Saber Abbaszadeh, Jafar Rezaian and Farhad Shahsavar*
DOI:10.2174/1875692117666190408113012

Genetic Polymorphisms of CYP2D6: Prevalence in Healthy Kurds open Access plus

Volume: 17  
Pp: 1-8
Muslih Abdulkarim Ibrahim*, Zalina Zahari*, Nurfadhlina Musa and Khoo Boon Yin
DOI:10.2174/1875692117666190416145331

Peculiaritie of Distribution of Polymorphic Variants of IL1Β Gene in Patients with Atherosclerosis and Metabolic Syndrome open Access plus

Volume: 17  
Pp: 1-8
Saranchina Yu.V*, Rossova NA, Khanarin NV, Kilina O. Yu, Dutova SV and Kulakova TS
DOI:10.2174/1875692117666190416150346

Differences in MDR1 (C3435T), CYP2D6, and CYP1A2 Genotype Frequencies between Patients with Treatment Failure to Antipsychotics and Healthy Russian Population open Access plus

Volume: 17  
Pp: 1-9
Tatiana Zhiganova *, Eugenia Radkova, Tatiana Sergeeva and Victoriia Volovnikova
DOI:10.2174/1875692117666190724141831

Pharmacokinetics and Systems Pharmacology of Anti-CD47 Macrophage Immune Checkpoint Inhibitor Hu5F9-G4 open Access plus

Volume: 17  
Pp: 1-11
Adarsh Mishra, Ishant Kataria and Sujit Nair*
DOI:10.2174/1875692117666190820105134

Mutation Analysis of ABL1 Gene and its Relation to the Achievement of Major Molecular Response in Indonesian Chronic Myeloid Leukemia Patients open Access plus

Volume: 17  
Pp: 1-7
Reni Widyastuti, Ikhwan Rinaldi*, Melva Louisa, Riki Nova , SpFK Instiaty and Rizky Priambodo
DOI:10.2174/1875692117666190925115852

Association between Paraoxonase 1(PON1) Gene Polymorphisms and PON1 Enzyme Activity in Indian Patients with Coronary Artery Disease (CAD) open Access plus

Volume: 16   Issue: 3
Pp: 219-229
Renuka Munshi*, Falguni Panchal, Ajay Chaurasia and Girish Rajadhyaksha
DOI:10.2174/1875692117666181227112119

Computational Studies of Molecular Targets Regarding the Adverse Effects of Isoniazid Drug for Tuberculosis open Access plus

Volume: 16   Issue: 3
Pp: 210-218
Nachimuthu Mohanasundaram and Talluri Sekhar*
DOI:10.2174/1875692116666181108145230

Molecular Mechanism of Metformin Associated Lactic Acidosis (MALA)- an In Silico Exploration open Access plus

Volume: 16   Issue: 3
Pp: 199-209
Siddiqur Rahman, Tamim Ahsan, Riajul Hossain, Tasnim Ahmed and Abu Ashfaqur Sajib*
DOI:10.2174/1875692117666181207121639

Metabolomics-based Approach to Pharmacotherapy Personalization: Advantages and Limitations open Access plus

Volume: 16   Issue: 3
Pp: 192-198
Dmitry L. Maslov*, Elena E. Balashova, Oxana P. Trifonova and Petr G. Lokhov
DOI:10.2174/1875692116666181008144905

Drug Abuse Treatment through Gene Manipulation Using Nanomedicine open Access plus

Volume: 16   Issue: 3
Pp: 182-191
Firoozeh Alavian*
DOI:10.2174/1875692117666181207120751

Oxidative Stress as a Key Signaling Pathway in Placental Angiogenesis Changes in Preeclampsia: Updates in Pathogenesis, Novel Biomarkers and Therapeutics open Access plus

Volume: 16   Issue: 3
Pp: 167-181
Enoch Odame Anto, Peter Roberts, Cornelius Archer Turpin and Wei Wang*
DOI:10.2174/1875692117666181207120011

Individualized Cancer Therapy, Future Approaches open Access plus

Volume: 16   Issue: 2
Pp: 156-163
Da-Yong Lu*, Ting-Ren Lu, Bin Xu, Jin-Yu Che, Ying Shen and Nagendra Sastry Yarla
DOI:10.2174/1875692116666180821095434

A Prospective Observational Pilot Study of Adverse Drug Reactions in Patients Admitted in the Geriatric Ward of a Tertiary Hospital in North India open Access plus

Volume: 16   Issue: 2
Pp: 147-155
Upinder Kaur, Sankha Shubhra Chakrabarti*, Bhanupriya Singh and Indrajeet Singh Gambhir
DOI:10.2174/1875692116666180830124924

Evaluation of Estrogen Receptor α and ß Genes Expression in Normal and Neoplastic Mammary Gland in Dogs by Real-time PCR open Access plus

Volume: 16   Issue: 2
Pp: 140-146
M.R. Nassiri*, S.A. Hosseini, S. Ghovvati and M. Zabetian
DOI:10.2174/1875692116666180907100151

Current Clinical Application and Response Prediction Biomarkers of PARP Inhibitors open Access plus

Volume: 16   Issue: 2
Pp: 108-117
Wei-Hua Shao, Lei-Yun Wang and Ji-Ye Yin*
DOI:10.2174/1875692116666180821152601

Dynamic Biomarkers of Response to Antiangiogenic Therapies in Colorectal Cancer: A Review open Access plus

Volume: 15   Issue: 2
Pp: 81-85
Jesus Rodriguez-Pascual* and Antonio Cubillo
DOI:10.2174/1875692115666170815161754

Beneficial Effects of Dietary Supplements Against Mitochondrial Dysfunction and Apoptosis in Neurodegenerative Diseases open Access plus

Volume: 13   Issue: 2
Pp: 93-98
Mohammed Akbar, Musthafa M. Essa, Byoung-Joon Song and Mohammed A.S. Khan
DOI:10.2174/1875692114999160502130439

Systematic 3D Screening of Amino Acid Mutations in Pharmacogenes open Access plus

Volume: 12   Issue: 4
Pp: 209-226
Thanawadee Preeprem and Greg Gibson
DOI:10.2174/1875692113666150408222109

Ethical, Political and Societal Implications of the Open Access Journal Movement in the Era of Economic Crisis, with Emphasis on Public Health Pharmacogenomics open Access plus

Volume: 11   Issue: 4
Pp: 312-315
Nicola L. Bragazzi
DOI:10.2174/1875692111666131126234122

Commercial Opportunities and Ethical Pitfalls in Personalized Medicine: A Myriad of Reasons to Revisit the Myriad Genetics Saga open Access plus

Volume: 11   Issue: 2
Pp: 98-109
Derek So and Yann Joly
DOI:10.2174/1875692111311020003

Situating Nutri-Ethics at the Junction of Nutrigenomics and Nutriproteomics in Postgenomics Medicine open Access plus

Volume: 11   Issue: 2
Pp: 162-166
Nicola L. Bragazzi
DOI:10.2174/1875692111311020008

Rethinking Pharmacogenomics Education Beyond Health Professionals: Addressing the “Know-Do” Gap Across the Personalized Medicine Innovation Ecosystem open Access plus

Volume: 10   Issue: 4
Pp: 277-287
Y. W. Francis Lam
DOI:10.2174/187569212803901828

Teaching Pharmacogenetics in Low and Middle Income Countries (LMICs): An Empirical Study of the Lessons Learned open Access plus

Volume: 10   Issue: 3
Pp: 217-225
Fatima Ghaddar, Karim Saba and Nathalie K. Zgheib
DOI:10.2174/187569212802510012

Modulating Blood-Brain Barrier Permeability and Treatment-Resistant Psychiatric Illness: Is Pituitary Neuroimaging a New Frontier? open Access plus

Volume: 10   Issue: 3
Pp: 182-184
Christopher Reist, Jogeshwar Mukherjee and Joseph C. Wu
DOI:10.2174/187569212802509979

A Broader Perspective on Personalized Medicine: Lessons from Discourse Analysis and Knowledge Translation open Access plus

Volume: 10   Issue: 3
Pp: 179-181
Bev J. Holmes
DOI:10.2174/187569212802510003

Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine open Access plus

Volume: 9   Issue: 4
Pp: 299-322
Murielle Bochud, Michel Burnier and Idris Guessous
DOI:10.2174/187569211798377135

The Genetic Privacy Carousel: A Discourse on Proposed Genetic Privacy Bills and the Co-Evolution of Law and Science open Access plus

Volume: 9   Issue: 4
Pp: 252-263
Edward S. Dove
DOI:10.2174/187569211798377207

Pharmacogenomic Research in South Africa: Lessons Learned and Future Opportunities in the Rainbow Nation open Access plus

Volume: 9   Issue: 3
Pp: 191-207
Louise Warnich, Britt I. Drogemoller, Michael S. Pepper, Collet Dandara and Galen E.B. Wright
DOI:10.2174/187569211796957575

Targeting Bcl-2 in Herceptin-Resistant Breast Cancer Cell Lines open Access plus

Volume: 9   Issue: 3
Pp: 184-190
Anatasha Crawford and Rita Nahta
DOI:10.2174/187569211796957584

Personalizing HER2-Targeted Therapy in Metastatic Breast Cancer Beyond HER2 Status: What We Have Learned from Clinical Specimens open Access plus

Volume: 7   Issue: 4
Pp: 263-274
R. Nahta, S. Shabaya, T. Ozbay and D. L. Rowe
DOI:10.2174/187569209790112337

Interview: Dr. Muin J. Khoury Discusses the Future of Public Health Genomics and why it Matters for Personalized Medicine and Global Health open Access plus

Volume: 7   Issue: 3
Pp: 158-163
Muin J. Khoury
DOI:10.2174/1875692110907030158

Functional Crosstalk Between β2-adrenoreceptor and Muscarinic Acetylcholine Receptor: Implications for Gene-Gene Interactions and Bronchodilatory Responses in Patients with Asthma and COPD open Access plus

Volume: 6   Issue: 4
Pp: 302-319
Takahiro Yoshikawa and Hiroshi Kanazawa
DOI:10.2174/187569208786733857

Do Estrogen Receptor β Polymorphisms Play A Role in the Pharmacogenetics of Estrogen Signaling? open Access plus

Volume: 6   Issue: 4
Pp: 239-259
Stephanie L. Nott, Yanfang Huang, Brian R. Fluharty, Anna M. Sokolov, Melinda Huang, Cathleen Cox and Mesut Muyan
DOI:10.2174/187569208786733820

Personalized Medicine, Bioethics and Social Responsibilities: Re-thinking the Pharmaceutical Industry to Remedy Inequities in Patient Care and International Health open Access plus

Volume: 6   Issue: 2
Pp: 108-120
Catherine Olivier, Bryn Williams-Jones, Beatrice Godard, Barbara Mikalson and Vural Ozdemir
DOI:10.2174/1875692110806020108